A

AdBio partners

12 employees

AdBio partners is a venture capital fund supported in particular by the National Seed-Fund.

Investor insights

Sectors invested in

Biotechnology15
Health Care6
Life Science4
Therapeutics2
Biotechnology and Diabetes2
Immunomodulation2
Healthcare2
vasculatis2
ANCA2
Santé2
monoclonal antibody2
Biopharma2
Pharmaceutical2
biotech2
Manufacturing2
Genetics1
RMAT1
gene therapy1
Tissue Engineering1
CAR-T1

Funding rounds participated in

$5M sweet spot round size

Most of their 20 investments are in rounds between $3.4M and $18M

Investor type

Micro VC
Venture Capital

Basic info

Industry

biotechnology research

Sectors

Date founded

2015

Investments made

A

Astraveus raised $18M on June 27, 2023

Investors: M Ventures and AdBio partners

U

Undisclosed raised $2.2M on June 19, 2023

Investors: AdBio partners

D

DiogenX raised $30M on May 10, 2023

Investors: JDRF T1D Fund, Omnes and AdBio partners

C

Calida Therapeutics raised $2.2M on April 6, 2023

Investors: AdBio partners

U

UNIVERCELLS raised $43M on October 19, 2022

Investors: SRIW, 3d investors, -, Adjuvant Capital, SFPI-FPIM, TheClubDeal SA and AdBio partners

T

Tridek-One raised $16M on September 15, 2022

Investors: Pureos Bioventures, Bioqube Ventures, Advent Life Sciences and AdBio partners

I

Integra Therapeutics raised $5.1M on December 2, 2021

Investors: Takeda UK Limited and AdBio partners

U

Undisclosed raised $4.7M on September 27, 2021

Investors: Crédit Mutuel Innovation, Pierre Fabre and AdBio partners

A

Agomab Therapeutics raised $74M on March 10, 2021

Investors: V-Bio Ventures, Omnes, Redmile Group, Pontifax Venture Capital, Andera Partners and AdBio partners

T

Thabor Therapeutics raised undisclosed on January 1, 2021

Investors: AdBio partners

FAQ